Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF | V.TLT.WT

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by skys1on Apr 05, 2021 11:01am
143 Views
Post# 32937006

RE:RE:RE:RE:RE:Any company’s management team has a duty to maximize

RE:RE:RE:RE:RE:Any company’s management team has a duty to maximize Agree Rumpl, for my money this Li Ka Shing agreement has far more positive ramifications than is known. For whatever reason, things were not happening fast enough with the PMC.  IMO, TLT decided to go elsewhere. TLT must feel this new agreement with such a well reputed facility should produce  better or more timely results. However, again IMO, that fact that Shing has such extremely deep pockets, is certainly a major benefit and factor. My guess is TLT will no longer have a need for further financing, and that is the major benefit of the agreement if that is the case.
I don't believe TLT just wanted a new research facility. Note that Roger has stopped his monthly buying. If there is more to this than meets the eye, it could be considered "material".
<< Previous
Bullboard Posts
Next >>